Manulife (Manufacturers Life Insurance)’s Aimmune Therapeutics AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-27,310
| Closed | -$941K | – | 3082 |
|
|
2020
Q3 | $941K | Sell |
27,310
-1,009
| -4% | -$21.5K | ﹤0.01% | 1683 |
|
|
2020
Q2 | $489K | Sell |
28,319
-994
| -3% | -$16.9K | ﹤0.01% | 1983 |
|
|
2020
Q1 | $423K | Buy |
29,313
+2,085
| +8% | +$53.3K | ﹤0.01% | 1914 |
|
|
2019
Q4 | $911K | Sell |
27,228
-1,308
| -5% | -$36.6K | ﹤0.01% | 1723 |
|
|
2019
Q3 | $596K | Hold |
28,536
| – | – | ﹤0.01% | 1922 |
|
|
2019
Q2 | $594K | Sell |
28,536
-712
| -2% | -$14.7K | ﹤0.01% | 1943 |
|
|
2019
Q1 | $654K | Buy |
29,248
+2,584
| +10% | +$60.8K | ﹤0.01% | 1924 |
|
|
2018
Q4 | $638K | Sell |
26,664
-1,974
| -7% | -$51.1K | ﹤0.01% | 1832 |
|
|
2018
Q3 | $781K | Sell |
28,638
-4,060
| -12% | -$115K | ﹤0.01% | 1959 |
|
|
2018
Q2 | $879K | Buy |
32,698
+5,838
| +22% | +$179K | ﹤0.01% | 1973 |
|
|
2018
Q1 | $855K | Sell |
26,860
-500
| -2% | -$17.6K | ﹤0.01% | 1946 |
|
|
2017
Q4 | $1.03M | Buy |
27,360
+176
| +0.6% | +$5.68K | ﹤0.01% | 1835 |
|
|
2017
Q3 | $674K | Sell |
27,184
-510
| -2% | -$11K | ﹤0.01% | 2063 |
|
|
2017
Q2 | $570K | Buy |
27,694
+6,690
| +32% | +$128K | ﹤0.01% | 2191 |
|
|
2017
Q1 | $456K | Buy |
21,004
+2,616
| +14% | +$53.7K | ﹤0.01% | 2261 |
|
|
2016
Q4 | $376K | Sell |
18,388
-748
| -4% | -$15.3K | ﹤0.01% | 2313 |
|
|
2016
Q3 | $287K | Buy |
19,136
+89
| +0.5% | +$1.2K | ﹤0.01% | 2482 |
|
|
2016
Q2 | $206K | Buy |
19,047
+10,961
| +136% | +$149K | ﹤0.01% | 2682 |
|
|
2016
Q1 | $110K | Buy |
8,086
+6,166
| +321% | +$96.2K | ﹤0.01% | 3007 |
|
|
2015
Q4 | $35 | Buy |
+1,920
| New | +$35.5K | ﹤0.01% | 3329 |
|
Manulife (Manufacturers Life Insurance)'s AIMT Position: Q4 2020 in Review
Manulife (Manufacturers Life Insurance) sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 27,310 shares — an estimated $941K sold.
Manulife (Manufacturers Life Insurance) first reported a position in AIMT in Q4 2015 and held it in 20 quarters. The position peaked at $1.03M in Q4 2017. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.
- Manulife (Manufacturers Life Insurance) reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 27,310 Aimmune Therapeutics shares in Q4 2020, an estimated $941K.
- Manulife (Manufacturers Life Insurance) first reported a position in Aimmune Therapeutics in Q4 2015 and held it in 20 quarters.
- Manulife (Manufacturers Life Insurance)'s Aimmune Therapeutics position peaked at $1.03M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2020, filed 12 Feb 2021.